The fact the two NKCC1 antagonists, bumetanide and ethacrynic acid, failed to block elevations in [Na+]i observed following ischemia-acidosis suggests that NKCC1 is not the site of action responsible for the mitigation of [Ca2+]i overload by these drugs under these conditions. Here, SLC12A2 is linked to ischemia.